Clinical Trials · NCT01163084

Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

TerminatedPhase 1/Phase 2Gonadorelin (Prohibited)
Phase
Phase 1/Phase 2
Recruitment status
Terminated
Sponsor
National Cancer Institute (NCI)
Enrollment
10
Start date
Jul 2010
Locations
5 sites, United States
Primary endpoint
Proportion of Patients With =< 5% Tumor Involvement
View Gonadorelin compound reference